Clinical Trial Update: A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury. [Phase 2]

View source ↗

Summary

A Phase 2 study by AstraZeneca is evaluating the efficacy, safety, and tolerability of AZD4144 in participants with sepsis-associated acute kidney injury; the t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury
• Sepsis

Drugs mentioned

• AZD4144

Snippet

Sponsor: AstraZeneca | Conditions: Sepsis, Acute Kidney Injury | Phase 2 | Status: RECRUITING